Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

China · Delayed Price · Currency is CNY

81.91

+0.38 (0.47%)

Jul 14, 2026, 4:00 PM EDT

-18.69% (1Y)

Market Cap	11.28B -21.0%
Revenue (ttm)	663.57M +26.2%
Net Income	202.44M +18.7%
EPS	1.47 +17.0%
Shares Out	137.75M
PE Ratio	55.80
Forward PE	n/a
Dividend	0.80 (0.98%)
Ex-Dividend Date	May 26, 2026

Volume	775,640
Open	81.53
Previous Close	81.53
Day's Range	79.20 - 82.30
52-Week Range	75.00 - 132.94
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of artificial bioprosthetic valve medical devices in China and internationally. It offers bovine pericardial, porcine aortic tissue, and limiting expandable artificial biological heart valves, as well as tricuspid annuloplasty ring for heart valve repair and treatment. The company also provides outflow tract single valve patch, pulmonary valved conduit, cardiothoracic biopatch, thoracic surgery biological patch... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2001

Employees 746

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688198

Full Company Profile

Financial Performance

In 2025, SHA:688198's revenue was 620.15 million, an increase of 23.57% compared to the previous year's 501.88 million. Earnings were 193.57 million, an increase of 32.28%.

Financial Statements